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Hyperactivity has been found to occur in 3 - 8% of the 
American school age population. These children present a 
challenge to teachers and parents alike. 
Although one is likely to hear or read quite a bit 
about hyperactivity at present, there is actually very little 
factual information available regarding it. It is known, for 
instance, that hyperactivity is much more prevalent among 
boys than it is among girls. It has also been found to occur 
most frequently among children from lower socio-economic back­
grounds. The reasons for these findings are unknown, however, 
as is the underlying cause for hyperactivity itself, although 
severa~ possible explanations have been offered. 
A number of theorists say that hyperactivity is organi­
cally based (that is, that it comes from something within 
the child). Some of the most commonly expounded explanations 
in this realm attribute hyperactive behavior to prenatal prob­
lems, early fetal developmental problems and inherited behav­
ior traits. Many experts believe that hyperactivity may be 
caused by a lag in the development of a specific part of the 
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brain or by a brain injury. This hypothesis is supported 
by the finding that many hyperactive children do have abnor­
mal electroencephalogram readings. 
Others believe hyperactivity may be diet-related, 
attributed to such factors as vitamin deficiencies, food 
sensitivities and allergies, low blood sugar, or lack of 
calcium. 
Some authors think sex-linked factors may contribute 
to hyperactivity, because of its great preponderance among 
boys. There may also be a genetic predisposition to hyper­
activity. 
Still other theories say that the environment in which 
a child grows up may contribute to hyperactive behavior. It 
is believed by some that if a child's home or classroom en­
vironment is too permissive or chaotic, characterized by 
poor management and inadequate interpersonal communication, 
the child never learns to develop self-control. Chronic 
emotional stress and continuous school failure may also 
trigger hyperactive behavior. 
A number of solutions to the problem of ijyperactivity 
have been offered, especially within the last few years, 
most of them based on one of these causal explanations. But 
because so little is actually known about hyperactivity, the 
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usefulness and safety of these different methods appears to 
vary from study to study, and indeed, from child to child. 
Purpose 
It was the purpose of this paper to review the liter­
ature on the different forms of treatment now available to 
hyperactive children. The safety and effectiveness of each 
was discussed and assessed. 
Definition of Terms 
1. Hyperactivity. Behavior characterized by exces­
sive distractability, impulsivity, short attention span and 
poor impulse control. (Note: In this paper, the terms hy­
peractivity and hyperkinesis were used interchangeably.) 
2. Drug Therapy. The use of any chemical which, when 
ingested, would cause changes to occur in a person's manner 
or behavior, usually to enhance physical or mental welfare. 
3. Placebo. A substance having no pharmacological 
effect but given to satisfy a patient who supposes it to be 
medicine; sooetimes used as an experimental control in 
testing the efficacy of a certain medicine. 
4. Behavior Management. Set of techniques designed 
to change one's observable behavior, in which appropriate 
behavior is rewarded and undesirable behavior is ignored. 
Scope and Limitations 
This paper was limited to research dealing primarily 
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with elementary school age hyperactive children. Emphasis 
was placed on forms of drug therapy used in treating these 
children. Several other forms of therapy were mentioned, 
although rather briefly. 
The paper was also limited to research published with­
in the last five years, with some earlier pertinent informa­
tion included. 
Summary 
In this chaper, a brief introduction to the nature of 
hyperactivity has been presented. 
The purpose of the paper was stated as a review of 
the forms of treatment available for controlling hyperactive 
behavior presented in current literature, with special em­
phasis on the safety and effectiveness of such treatment. 
The terms hyperactivity, drug therapy, placebo and 
behavior management were defined. 
The limitations of the paper were stated as research 
done primarily within the last five years dealing with hy­
peractive children of elementary school age. It was also 
mentioned that forms of drug therapy were especially empha­
sized. 
Chapter II 
Review of Literature 
Because hyperactive children may be found in all 
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socioeconomic groups and in countries throughout the world, 
a number of solutions to this problem have been proposed. 
The Use of Drug Therapy 
At the present time, drug therapy seems to be the 
most common form of intervention used in the treatment of 
hyperactivity. Although some controversy has arisen in 
recent years over the safety and adequacy of this form of 
treatment, it continues to be widely utilized. 
In this form of therapy, stimulant drugs, or ampheta­
mines, are prescribed for the hyperactive child. The fact 
that amphetamines serve to stimulate adults and normal chil ­
dren, but act in the exact opposite manner on hyperactive 
children, remains an unexplained paradox. Yet, apparently, 
this is indeed what happens. Several researchers have 
attempted to explain the occurrence of this phenomenon. 
Glennon & Nason (1974), for instance, believe that hyper­
active behavior is evidence of slow cortical maturation and 
that "these drugs stimulate the cortex to integrate behavior. 
The quantity of activity is actually increased as we would 
expect it to be. It is the 'restlessness' which is dimin­
ished. Because the child can function more fully in his 
thinking and responses, his behavior reverts to normal" 
(p.	 819). 
Another possible explanation of why amphetamines seem 
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to decrease hyperactivity is offered by Cole (1975). He 
believes these drugs may "slow the transmission of nerve 
impulses in the brain of hyperkinetic children without 
actually sedating the child . . . nerve impulses may be 
transmitted too rapidly in the hyperkinetic child, and stim­
ulant drugs act to achieve a chemical balance, allowing the 
brain to function in a more normal manner" (p. 31). 
Or, stated this same author, amphetamines "may stim­
ulate the reticular activating system of the lower brain 
which, in turn, could result in an increase in the alert­
ness and focused attention of the child" (Cole, 1975, p. 32). 
Although none of these explanations has been proven, 
future research in this area may substantiate one or more 
of them. What is known, however, is that, whatever the 
reason, amphetamines have been found by many to be a success­
ful means of controlling hyperactive behavior in children. 
Ritalin (also known as methylphenidate) and Dexadrine 
seem to be the most commonly prescribed drugs in treating 
hyperkinesis. Pemoline (Cylert) is another type of stimu­
ant drug which is also sometimes recommended, but less fre­
quently than either Dexadrine or Ritalin. 
Research Supporting the Use of Drug Therapy 
A great deal of research can be found to support and 
recommend the use of drugs in the treatment of hyperactivity. 
Treating Hyperactivity 
8 
A number of authors believe that medication can aid 
hyperactive children in tolerating stress and in so doing, 
facilitates healthy psychological and emotional development. 
Others say that drugs can also help cognition, as well as 
enable children to attend better, which improves memory 
ability. 
Lerer & Lerer (1977) reported, for example, on a study 
conducted using 27 adolescents, all of whom underwent a 
60-day trial of Ritalin medication. After the trial, 16 of 
the 27 adolescents showed improvement in behavior, as rated 
by parents and teachers. The adolescents were noted to have 
an increased ability to attend and to concentrate. An im­
provement in academic achievement was also reported, in 
addition to a decreased level of anxiety. No ill side effects 
were displayed by any of the adolescents participating in 
the study. 
Lerer & Lerer believe that these findings demonstrate 
a trial use of medication (they recommend 30 to 60 days) to 
be useful in determining the effectiveness of drug therapy 
for a particular child. However, it should be pointed out 
that no measures have been identified which could aid diag­
nosticians in predicting which children or adolescents would 
be likely to benefit positively from medication, before such 
medication is administered. 
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In a study reported by Page, Janicki, Bernstein, 
Curron & Michelli (1974), 238 children, ranging in age 
from six to twelve, were given once-daily dosages of Pemo­
line. Under this form of medication, improvements in be­
havior as measured by parents, teachers, and physicians were 
recorded. In addition, improvement in cognitive and per­
ceptual functioning, as measured by (un-named) psychologi­
cal tests was reported. The blood pressure and pulse rates 
of the children under medication remained stable, but "mini­
mal side effects" (p. 501) were reported, the primary ones 
being insomnia and anorexia. Some children also complained 
of stomach ache, mild depression, nausea, dizziness, head­
ache and fatigue. The author of this paper questions how 
"minimal" these effects may be, especially in children. 
Wade (1976) reported on a study of motor performance, 
in which 12 normal children and 12 hyperactive children 
were assessed in their ability to maintain equilibrium on 
a square platform that rotated about a central axis. The 
hyperactive children were tested twice: once on medication 
(Ritalin) and once after having been given a placebo. It 
was found, according to this study, that the hyperactive 
children performed more like their normal peers while they 
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were on medication than they did when they were on the 
placebo. Also, it was found that the subjects were less 
consistent in performance while on the placebo. The author 
felt that these findings supported the use of medication in 
helping hyperactive children perform like their normal peers 
on motor skill tasks. He also hypothesized that medication 
may be useful for these children in initial motor skill 
learning. 
Millichap (1978) reported on a study of 36 elementary 
school-age boys, all receiving daily doses of 10 to 20 milli­
grams of Ritalin for an average period of 16 months. The 
purpose.__ of this study was to disclaim the theory put forth 
by some researchers that medication on a daily basis may 
have an adverse effect on children's physical growth. A 
distribution of the heights and weights of all the boys was 
recorded, and results showed no significant difference in 
these measurements before and after treatment. In fact, the 
rates of annual growth were actually found to be above aver­
age in 64% of the boys. 
This shows, says Millichap, that "relatively small 
doses of methylphenidate (Ritalin) given intermittantly as 
an adjunct to remedial education are without serious toxicity 
and do not cause growth suppression in hyperactive children. 
Indeed, in children between 5 and 8 years and in a majority 
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of older school children, a stimulant effect on growth may 
be noted when daily doses of 10 to 20 milligrams of methyl­
phenidate are used" (p. 570). However, Millichap advises 
against long-term use of medication or bigger dosages when 
when he goes on to say, "The prescription of larger doses 
on a continuous schedule is generally unnecessary and is 
probably inadvisable" (p. 570). 
Some researchers support the use of stimulant drugs 
only under certain conditions. They suggest that the cause 
of a particular child's hyperactivity should be considered 
when considering the type of intervention to be used. These 
authors believe that children whose hyperkinesis is organi­
cally based may benefit more from medical intervention than 
those whose hyperactivity is environmentally caused. If the 
cause of the child's hyperkinesis is environmental in nature, 
resulting from a loosely structured or unstructured home 
atmosphere and inconsistent child-rearing practices, it 
appears that other types of intervention programs may be 
more beneficial. 
Importance of Communication Among 
Physician, Teacher and Parents 
Although, as has been stated, medical trea'tment of 
hyperactive children is advocated by many, its supporters 
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recommend a high level of communication among the prescrib­
ing doctor, the child's parents and his school. Wei thorn & 
Ross (1975) advise, "Physicians should prescribe medication 
for hyperactivity only when they are satisfied that both 
home and school are aware of the need for relevant periodic 
feedback on behavior and learning and are prepared to make 
a commi tment to provide it" (p. 460). 
Doctors have been accused of prescribing drugs too 
readily to hyperactive children, but Sandoval, Lambert & 
Yandell (1976) reported on a study based on the responses 
of 48 physicians to an extensive questionnaire. The results 
showed that, while stimulant drugs were found to be the most 
common form of intervention prescribed, these doctors also 
often recommended consultation with school authorities, re­
ferrals for special education placement and psychotherapy 
for the hyperactive child and his family. "These findings 
suggest, contrary to many publicly held views, that physi­
cians in private practice consider multiple, rather than 
single treatment, recommendations for hyperactive children 
as being most appropriate" (Sandoval, Lambert & Yandell, 
1976, p. 331). 
Wei thorn & Ross (1975) proposed that "there should be 
programs for monitoring. behavioral consequences so that 
relevant information can be exchanged between the prescribing 
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physician and the teacher who is in a position to observe 
the behavioral effects of the medication" (p. 458). 
These authors also conducted a survey of doctors, the 
results of which indicated that "the number of cases in 
which teacher-physician contact occurs . . . falls far short 
of that which could be considered adequate monitoring" (Weit­
horn & Ross, 1975, p. 458). 
Open communication between the teacher and the school 
nurse is also seen as important, since the nurse may often 
be responsible for monitoring a child's medication in school. 
Based on findings from a questionnaire completed by 138 teach­
ers and nine school nurses, Okolo, Bartlett & Shaw (1978) 
found that nurses were, in general, more involved in the dis­
tribution and monitoring of a hyperactive child's medication 
and that teachers often knew little about it. Most of the 
teachers questioned did indicate, however, that they thought 
they should have and wanted to have a larger role in the 
medication process. These authors felt that the teacher 
should be advised as to medication received by any child in 
his or her classroom. They also stated that he or she may 
be able to provide valuable feedback to the nurse regarding 
a medicated child, because as a rule the teacher has much 
more active involvement with the child than the school nurse 
is apt to have. "Only when school and doctor willingly 
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participate in a joint effort to remediate the problem of 
the hyperactive child will a clear and continuous model of 
referral and evaluation be possible" (Okolo, Bartlett & 
Shaw, 1978, p. 650). 
Murray (1976) agreed that teachers have an advantage 
in being more closely involved with their students than either 
the child's physician or school nurse. Because the teacher 
is thus more familiar with the child and his behavior, Murray 
believed the teacher should be the individual to administer 
any medication to the child in school. He felt that it may 
also be the teacher's role to suggest medication as a form 
of treatment, if the teacher feels medicating the hyperactive 
child would lead to the enhancement of 'the learning atmos­
phere in the classroom for all concerned. However, Murray 
advised that other types of intervention should be tried first 
in the classroom; only if these fail should medication be 
suggested by the teacher. Once the child is actually re­
ceiving medication on a regular basis, the teacher should be 
especially aware of any behavioral or academic changes. All 
observations should be shared with the child's parents and 
physician. 
Axelrod & Bailey (1979) offered some specific guide­
lines for teachers to follow if drugs are being administered 
to a hyperactive child at school. 
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First, they proposed that a copy of the doctor's 
prescription should be kept on file, as should a statement 
of the purpose for administering the drug and a form signed 
by the parents of the child requesting that medication be 
given during school. 
Next, it was suggested that medication be sent to 
school only via a responsible adult; the child himself should 
not carry it. All medication should be clearly labeled and 
fresh and any medicine that is not going to be immediately 
used should not be kept in the classroom. 
Axelrod & Bailey also advocated strict record-keeping 
regarding the actual administration of the drug. The time 
the drug is given, the dosage received and the name of the 
individual administering the medication should all be in­
cluded. 
Warnings Against Use of Drug Therapy 
Although it has been found that medication is cur­
rently the most common means of treating hyperactivity, cau­
tion is advised by many in prescribing and administering 
stimulant drugs to hyperactive children. 
Walker (1975) contended that the method of interven­
tion should be based primarily on the cause of the hyper­
activity evident in the child. He stated that he believes 
"
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hyperkinesis may be caused by physical problems, such as 
lack of oxygen to the blood due to a heart defect, a low 
level of glucose in the system, a lack of calcium or other 
dietary deficiencies. These conditions could be corrected 
surgically or through other types of medical intervention, 
claimed Walker (1975), and prescribing stimulants would 
merely "mask the symptoms" (p. 354) without curing the hyper­
activity. 
"Traumatic childhood experiences and unresolved con­
flicts or other psychological problems could also contribute 
to hyperactive behavior," wrote Walker (1975, p. 355). In 
this case, the child would benefit more from psychotherapy 
than from drug treatment. "It makes no scientific sense to 
suppress hyperactivity with drugs, without diagnosing medi­
calor psychological problems" (Walker, 1975, p. 358). 
Although it is generally conceded that drug therapy 
can have a significant effect on observable behavior in hyper­
active children, including reducing activity level and dis­
tractability, decreasing disruptive behavior, and increasing 
ability to attend, no significant drug effects have been 
found on scholastic achievement (Rie, Rie, Stewart, and 
Ambuel, 1976; and Axelrod & Bailey, 1979). It appears that 
drug therapy does not improve a hyperactive child's actual 




the child's academic performance does improve after the 
prescription of stimulant medication, as is sometimes the 
case, this is generally believed to be attributed to the 
decrease of disruptive behaviors and improved ability to 
attend. 
A number of other shortcomings related to drug 
prescription and supervision for hyperactive children were 
discussed by Neisworth, Kurtz, Ross & Madle (1976). 
First, these authors state that doctors often rely 
too heavily on "subjective impressions of parents and teach­
ers as a data base to assist in the formulation of a diag­
nosis" (p. 149). Although parents and teachers may provide 
valuable input, their observations and recommendations should 
not be the sole basis of drug prescription. 
Secondly, "psychological tests of questionable reli ­
ability and validity are fpequently used to identify 'soft 
signs' of organic dysfunction" (Neisworth, Kurtz, Ross & 
Madle, 1976, p. 150). It was claimed by these authors that 
such psychological tests offer only "highly inferential evi­
dence of organic dysfunction" (p. 150). More accurate and 
reliable measures should be devised to assess any dysfunc­
tion more critically. 
Neisworth, Kurtz, Ross & Madle (1976) also stated their 
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concern that once drugs have been prescribed for a child, 
the administration and treatment effects of these drugs are 
monitored in a haphazard manner. 
These authors proposed a few minimal standards to be 
followed prior to the prescription of drugs. First, they 
recommended the "translation of the diagnosis and caretaker 
impressions into observable . . . school and home behaviors" 
(Neisworth, Kurtz, Ross & Madle, 1976, p. 150), so that drug 
prescription can be based on more objective, scientific grounds. 
Next, they recommended the "collection of baseline data 
on the occurrence of the operationalized behaviors to deter­
mine in a more objective manner the severity of the syndrome 
in the natural environment" (Neisworth, Kurtz, Ross & Madle, 
1976, p. 150). 
The third step involved deciding if the situational 
evidence supports the clinical impressions regarding the child 
and his behavior, perhaps by comparing the child under consi­
deration to others. Also, it was pointed out, this informa­
tion can act as a baseline against which treatment effects 
can be assessed. 
The final step entailed "continued data collection on 
the target behaviors after drug treatment has begun" (p. 150). 
In this way, adjustments to the needs of individual children 
can be made, and possible side effects related to drug usage 
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can also be detected. 
Axelrod & Bailey (1979) also reported on possible 
adverse side effects connected with stimulant drug therapy. 
It has been found that hyperactive children subjected to 
long periods of medication may exhibit irritability, psy­
chological depression, nausea, insomnia or dizziness. They 
may also suffer from gastrointestinal distress, fine tremors 
or coldness of the extremetries and they have sometimes been 
found to display "flat emotional responses" (Axelrod & Bailey, 
1979, p. 547) when under the influence of medication. 
Another concern mentioned by several authors (Axelrod & 
Bailey, 1979, and Cole, 1975) is the fact that children on 
stimulant medication often display an elevation of heart rate 
and blood pressure. It was suggested that these vital signs 
should be carefully monitored and recorded for the duration 
of the medication process. 
Cole (1975) also found that children receiving stimu­
lant medication sometimes exhibited a diminished appetite 
and loss of weight, which could result in a depression of 
overall physical growth. 
Some authors voiced concern over the possibility that 
long-term dosages of stimulant drugs to hyperactive children 
may lead to drug dependency in later years. Glennon & 
Nason (1974), however, did not see much risk in this. They 
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believed that the vast majority of children regard medica­
tion as therapy and are willing and anxious to stop taking 
it. 
As can be seen from the previous findings, some degree 
of caution is advised in the use of drug therapy in the 
treatment of hyperactivity, even by those who advocate it. 
It should also be pointed out once again, though, that there 
are those who strongly oppose the use of medication under 
any circumstances. Rie, Rie, Stewart & Ambuel (1976) stated, 
"Sole reliance on drugs, and uncritical acceptance of global 
positive evaluations of its effects by parents and teachers 
should be avoided ... at all costs" (p. 321). 
Problems in Evaluating Drug Therapy 
The reasons for some of the controversy regarding drug 
use are related to some key methodological problems in the 
evaluation of medication. Some of these problems were listed 
by Adelman & Compass (1977). 
The first issue mentioned dealt with sUbject selection 
in studies designed to test the effectiveness of drug therapy. 
For one thing, said the authors, subjects in these studies 
are usually referred, not selected. This may result in "a 
very heterogeneous group which may differ significantly with 
reference to a number of cri tical dimensions" (Adelman & 
Compass, 1977, p. 392). Or, said the authors, studies may 
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claim to sample different populations, but because of over­
lapping or poorly defined labels, some subjects from the 
same population (or even from an entirely different, un­
related group) may be used. Also, the procedures for select­
ing hyperactive subjects are often very subjective, relying 
on judgments of people who may use different criteria in 
making their selections. 
The second problem in evaluating the effectiveness of 
drug therapy has to do with experimental controls, according 
to Adelman & Compass (1977). Included within this category 
were possible placebo effects (where the child showed im­
provement because he merely thought he was receiving actual 
medication) and confusing drug effects with diminished hyper­
active behavior due to the passage of time. 
The third methodological problem cited was that of 
measurement. According to Adelman & Compass (1977), accurate, 
systematic forms of measurement, in terms of both validity 
and reliability, have not yet been devised to assess behavior 
and gauge learning. 
Because of these problems in evaluating the use of 
drugs in treating hyperactive children, Adelman & Compass 
stated that no conclusive research supporting the efficacy 
of stimulants as treatment for improving academic perfor­
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mance, or as treatment for behavior problems, has been done. 
They also felt there has been no satisfactory research (ei­
ther positive or negative) regarding long-term side effects. 
They summed up their evaluation by stating that it "remains 
unproven that children taking stimulant drugs manifest im­
portant positive changes over the long term (and for many 
not even over the short term) in their behavior at school and 
at home" (Adelman & Compass, 1977, p. 409). 
Geographical Considerations 
It is interesting to note that while much controversy 
still revolves around the issue of drug therapy for hyper­
kinetic children, the use of medication appears to be on the 
increase in American schools. There also seem to be some 
geographical factors involved in the prescription of drugs to 
hyperactive youngsters. Conway (1976) found, through ques­
tionnaires answered by school psychologists, that fewer chil­
dren appear to be drugged in rural areas than in urban areas. 
In some city districts, as many as 15 to 20% of all elemen­
tary school-aged children were found to be on medication, as 
compared to 1 to 6t% in rural areas. Conway offered several 
possible explanations for these findings. Perhaps, rapidly 
expanding school districts, in large population genters, may 
be more inclined to advocate the use of drugs for controlling 
behavior. Then, too, the fact that most urban areas are often 
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places of high family mobility may contribute to greater use 
of drugs, since "constant relocation is one of the factors 
often cited by sociologists and psychologists as contribut­
ing to emotional problems, particularly among young children" 
(Conway, 1976, p. 442). Whatever the real reason, drugs do 
appear to be prescribed more extensively in densely populated 
areas than in rural ones. 
Alternatives to Drug Therapy 
Although it has been pointed out that medication is a 
widely used means of treating hyperactivity in children, 
several alternatives to drug prescription do exist. 
Behavior Modification Techniques 
Several authors believe that the use of strict behavior 
therapy can reduce hyperkinesis in children. 
Stableford, Butz, Hasazi, Leitenberg & Peyser (1976) 
conducted a study in which they found that "behavior therapy 
. . . was effective in controlling hyperactive behavior" 
(p.302). 
These authors reported on two hyperactive boys, both of 
whom were originally receiving dosages of stimulant drugs. 
Eight-year-old Fred was receiving Ritalin, which was gradu­
ally replaced with a placebo. Gregg, a 9-year-old, was phased 
off Dexadrine in the same way. Finally, even the placebos 
were discontinued, and strict behavior modification techniques, 
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including rating scales of behavior at home and at school 
and the use of contingency management procedures, were im­
plemented with both boys. In each case, this program was 
successful in producing on-task and appropriate behavior. 
Weissenburger & Looney (1977) also supported the use 
of behavior therapy in controlling hyperkinesis. They espe­
cially recommended it for the classroom setting and saw two 
distinct advantages in using behavior therapy, as opposed to 
other forms of treatment, at school. First, they claimed, 
using behavior management techniques could have a direct 
beneficial effect on classmates as well as on the hyperactive 
child himself, thereby improving the behavior of the entire 
group. Also, stated Weissenburger & Looney, behavior therapy 
can be used as a preventative measure, to keep inappropriate 
behaviors from developing and becoming established. 
As has been shown, behavior therapy is viewed by many 
as a safe and often successful way of controlling hyperactiv­
ity. However, the main drawback in the use of this form of 
treatment, according to Stableford, Butz, Hasazi, Leitenberg 
& Peyser (1976), is that it is often difficult and time-con­
suming to implement. Because of this, said the authors, "it 
is possible that, despite the chances of adverse' side effects, 
many parents will choose stimulant drugs over behavior therapy 




Several researchers have linked hyperactivity to food 
additives such as artificial colors, flavors and preserva­
tives. Finegold (1975 and 1977) claimed that eliminating 
these elements from a child'S diet would improve his behav­
ior, sometimes drastically. 
It has also been stated that some children appearing 
hyperactive may be suffering from nutritional allergies or 
other diet-related deficits, such as mineral or vitamin defi­
ciencies. If these deficits exist, they may be treated by 
the ingestion of megadoses of the needed nutrients. Aller­
gies may be treated by attempting to eliminate problem foods 
from the child'S diet. 
Although nutritional therapy has been demonstrated to 
be beneficial in illiciting positive behavior changes in some 
children, it is still considered an "unproved treatment" 
(Adler, 1978, p. 656) and caution has been advised in its use. 
Other Alternatives 
Krippner (1975) reported on an alternative to drug 
therapy employed by Churchill School in New York City. The 
school offered a program for hyperactive children consisting 
of three major components. 
First, stated Krippner, sensory-motor training was 
stressed, with special emphasis on language stimulation, 
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and the introduction of neurol patterns (such as crawling 
or creeping) believed to have been omitted during the child's 
early development. 
Next, orthomolecular medicine was practiced. Mega­
vitamins were prescribed for most students, based on the 
rationale that "large amounts of vitamins will enable the 
body to fulfill its requirements despite an existing disor­
der" (Krippner, 1975, p. 435). 
The final component used by the school was an open­
classroom approach to instruction, emphasizing exploration 
by the students. Classrooms were divided into interest areas. 
Contracts between student and teacher were widely utilized, 
with the teacher providing materials, giving assistance as 
needed, and recording pupil progress. In this way, stated 
Krippner (1975), "the hyperactivity of each child is thus 
channeled into constructive pursuits" (p. 436). The self­
concept of the hyperactive child was also thought to be en­
hanced. 
According to Krippner (1975), this alternative form of 
treatment appeared to be a very successful means of dealing 
with hyperkinetic behavior. 
Summary 
In this chapter, literature dealing with treatment 
forms for hyperactive children was reviewed. 
Treating Hyperactivity 
27 
It was shown that drug therapy is currently the most 
popular form of treating hyperkinesis, and articles support­
ing the use of this type of intervention were cited. The 
importance of open communication among parents, school and 
physician regarding a child receiving medication has been 
stressed. However, the fact that drug therapy is discouraged 
by some authors was also mentioned and possible dangers in­
volved with drug use were listed. Methological problems in 
the evaluation of drug therapy were also discussed. Finally, 
geographical considerations for the use of medication with 
hyperactive children were mentioned. 
Alternative treatments to drug therapy were also dis­
cussed, including behavior therapy, diet-related treatments 
and several other alternatives, such as sensory-motor train­
ing, orthomolecular medicine and open-classroom techniques 
for the hyperactive child in school. 
Chapter III 
Conclusion 
After reviewing the literature dealing with hyperactiv­
ityand the methods available for treating it, this author 
has been able to come to several conclusions regarding this 
topic. 
First, there is still much that needs to be learned 
about hyperactivity itself, including its origin and cause. 
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It is this author's opinion that after some of the basic 
questions involving hyperkinesis are answered, more clear­
cut solutions to the problem may be made available. 
Secondly, more research needs to be done concerning 
all forms of intervention currently being used with children 
labeled as hyperactive. Much controversy still surrounds 
each of the treatment forms discussed in this paper, espe­
cially drug therapy. 
Another conclusion this author has come to is that a 
decision on the form of treatment prescribed should be a 
joint one, involving input from family members, school and 
medical personnel and possibly even the child himself. Also, 
this author believes that no decision regarding treatment 
should be viewed as permanent or static, but should be sub­
ject to review and change, based on the changing needs of 
the child. 
Finally, it is the opinion of this author that, al­
though some dangers may be involved, drug therapy is probably 
the best means of treating hyperactivity at the present time. 
Its biggest advantage is that it is much easier to implement 
than other forms of treatment and this factor alone undoubted­
ly contributes, at least partly, to its popularity. Although 
some undesirable side effects may accompany the use of drugs, 
these symptoms may be preferable to consistent, overt hyper­
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active behavior in the home and classroom. Hopefully, care­
ful monitoring of drug therapy can help minimize the dangers 
of drug intake. 
Summary 
In this chapter, the observations and conclusions of 
the author of this paper have been stated. 
Several conclusions regarding hyperactivity and its 
various treatment forms have been drawn. First, that more 
research dealing with hyperkinesis and methods of treating 
it is needed. Also, that communication among those involved 
in any form of intervention is essential, so that interven­
tion techniques may be reassessed and updated if necessary. 
And lastly, that at the present time, medical intervention 
in the form of drug therapy seems to be the most popular, 
most efficient, and most effective way to treat hyperactivity, 
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